This brand name is authorized in Nigeria.
The drug RANICEF contains one active pharmaceutical ingredient (API):
1
|
Cefdinir
UNII
CI0FAO63WC - CEFDINIR
|
|
As with other cephalosporins, bactericidal activity of cefdinir results from inhibition of cell wall synthesis. Cefdinir is stable in the presence of some, but not all, β-lactamase enzymes. As a result, many organisms resistant to penicillins and some cephalosporins are susceptible to cefdinir. |
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-9760 | Tablet | Ranicef 300 Tablet TAB 300 mg 1 X 10 | Ranicef 300 Tablet A4-9760 Ranicef CEFDINIR ANTIBIOTICS CEFDINIR USP 300MG TABLETS 1 X 10 PRESCRIPTION ONLY MEDICINE TREATMENT OF INFECTIONS CAUSED BY SUSCEPTIBLE MICRO-ORGANISMS FIDSON HEALTHCARE PLC. NIGERIA STERILE-GENE LIFE SCIENCES PVT. LTD INDIA 01/27/2022 01/26/2027 | 27/01/2022 |
| A4-9762 | Suspension | Ranicef 250 Oral Suspension SUSP 250 mg/5 mL 1 X 60ML | Ranicef 250 Oral Suspension A4-9762 Ranicef CEFDINIR ANTIBIOTICS CEFDINIR USP 250MG/5ML SUSPENSION 1 X 60ML PRESCRIPTION ONLY MEDICINE TREATMENT OF INFECTIONS CAUSED BY SUSCEPTIBLE MICRO-ORGANISMS FIDSON HEALTHCARE PLC. NIGERIA STERILE-GENE LIFE SCIENCES PVT. LTD INDIA 01/27/2022 01/26/2027 | 27/01/2022 |
| A4-9763 | Suspension | Ranicef 125 Oral Suspension SUSP 125 mg/5 mL 1 X 60ML | Ranicef 125 Oral Suspension A4-9763 Ranicef CEFDINIR ANTIBIOTICS CEFDINIR USP 125MG/5ML SUSPENSION 1 X 60ML PRESCRIPTION ONLY MEDICINE TREATMENT OF INFECTIONS CAUSED BY SUSCEPTIBLE MICRO-ORGANISMS FIDSON HEALTHCARE PLC. NIGERIA STERILE-GENE LIFE SCIENCES PVT. LTD INDIA 01/27/2022 01/26/2027 | 27/01/2022 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01DD15 | Cefdinir | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-9760, A4-9762, A4-9763 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.